Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators Medical Dialogues Bureau14 Sept 2019 9:15 AM ISTValisure said in its report that it found the impurity in both Sanofi SA's branded Zantac as well as generic versions of the drug. But the FDA would...
